WHO ICTRP trial
A single subcutaneous injection dose, dose-escalation phase I study on the…
ChiCTR-ONRC-12003869 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONRC-12003869 |
|---|---|
| Public title | A single subcutaneous injection dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating proteininjection ( CHO cell ) in patients with chronic kidney disease with anaemia |
| Scientific title | A single subcutaneous injection dose, dose-escalation phase I study on the tolerability and safety of recombinant erythropoiesis stimulating proteininjection ( CHO cell ) in patients with chronic kidney disease with anaemia |
| Primary sponsor | Shanghai Changzheng Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Chronic kidney disease with Anaemia |
| Interventions | 2.50µg/Kg subcutaneous infusion group:Single dose of study drug through subcutaneous infusion: 2.50µg/Kg;3.00µg/Kg subcutaneous infusion group:Single dose of study drug through subcutaneous infusion: 3.00µg/Kg |
| Registration date | Nov 2, 2012 |
| Target size | 2.50µg/Kg subcutaneous infusion group:3;3.00µg/Kg subcutaneous infusion group:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: